Akari Therapeutics Plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 02/18/2026 | 20.58 K | $5.95 K | 100.00% | 6,299.15% | |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 2.72 M | $787.23 K | 100.00% | 8.09% |
| CRESSET ASSET MANAGEMENT, LLC | 02/17/2026 | 822.47 K | $237.69 K | 0.00% | 2.44% |
| WARBERG ASSET MANAGEMENT LLC | 02/13/2026 | 308.34 K | $88.71 K | 100.00% | 0.92% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 146.02 K | $42.20 K | 0.00% | 0.43% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 79.24 K | $22.90 K | 0.00% | 0.24% |
| JANE STREET GROUP, LLC | 02/12/2026 | 71.64 K | $20.71 K | 100.00% | 0.21% |
| 02/12/2026 | 69.25 K | $20.01 K | 100.00% | 0.21% | |
| CWA ASSET MANAGEMENT GROUP, LLC | 01/07/2026 | 55.00 K | $15.90 K | 100.00% | 0.16% |
| XTX TOPCO LTD | 02/17/2026 | 49.02 K | $14.17 K | 100.00% | 0.15% |
| UBS GROUP AG | 01/29/2026 | 32.86 K | $9.50 K | 54,658.33% | 0.10% |
| CERITY PARTNERS LLC | 02/11/2026 | 23.64 K | $6.83 K | 0.00% | 0.07% |
| STONEX GROUP INC. | 02/12/2026 | 21.30 K | $6.15 K | 100.00% | 0.06% |
| INDEPENDENT ADVISOR ALLIANCE | 02/04/2026 | 17.08 K | $4.94 K | 56.84% | 0.05% |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 6.80 K | $1.97 K | 0.00% | 0.02% |
| ACCENT CAPITAL MANAGEMENT, LLC | 02/09/2026 | 5.00 K | $1.45 K | -50.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 410 | $118 | 173.33% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 200 | $58 | 100.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 02/13/2026 | 50 | $14 | 0.00% | 0.00% |
| CORNERSTONE PLANNING GROUP LLC | 02/02/2026 | 5 | $1 | -28.57% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 3 | $1 | 0.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 0 | $0 | -100.00% | 0.00% |
| OMNIA FAMILY WEALTH, LLC | 01/16/2026 | 0 | $0 | -100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akari Therapeutics Plc institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Akari Therapeutics Plc. The most heavily invested institutionals were:
IFP Advisors, Inc: 7,431
SBI Securities Co., Ltd.: 5
JANE STREET GROUP, LLC: 0
Accent Capital Management, LLC: 0
UBS Group AG: 0
HighTower Advisors, LLC: 0
13.23% of Akari Therapeutics Plc stock is owned by institutional investors.
Institutional investors have bought a total of 3.99 M shares in the last 24 months. This purchase volume represents approximately $997.51 K in transactions.